Literature DB >> 892912

Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

S Miyazaki, M Iwasaki, G Sakaguchi.   

Abstract

Clostridium botulinum type D progenitor toxin was purified. The addition of ribonucleic acid to the whole culture helped initial acid precipitation of the toxin. As with type B, both L (16S) and M toxins (12S) obtained from a hemagglutinin-positive strain, whereas M toxin only was produced by a hemagglutinin-negative strain. M toxin (molecular weight, 300,000) consisted of one molecule each of a toxic (molecular weight, 170,000) and a nontoxic component (molecular weight, 130,000); L toxin consisted of both components plus hemagglutinin. The specific toxicity of M toxin was 5 X 10(8) mean lethal doses per mg of N; that of L toxin was 2.4 X 10(8) mean lethal doses per mg of N. These toxins were fully or nearly fully active, but in un-nicked form. Trypsinization caused nicking in the toxic component, forming a molecule made up of two peptide chains with molecular weights of 110,000 and 60,000; there was little or no increase in toxicity. The toxic component of type D was not antigenically related to that of type C, whereas the nontoxic component was antigenically indistinguishable from that of type C. The toxicities of both L nad M toxins of the hemagglutinin-positive strain were increased twofold by trypsinization. Neither toxin contained the C2 toxic factor elaborated by C and D strain.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 892912      PMCID: PMC421134          DOI: 10.1128/iai.17.2.395-401.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.

Authors:  M A CARDELLA; J T DUFF; B H WINGFIELD; C GOTTFRIED
Journal:  J Bacteriol       Date:  1960-03       Impact factor: 3.490

2.  Hemagglutination by Clostridium botulinum type D.

Authors:  M STERNE
Journal:  Science       Date:  1954-04-02       Impact factor: 47.728

3.  Disk electrophoresis of basic proteins and peptides on polyacrylamide gels.

Authors:  R A REISFELD; U J LEWIS; D E WILLIAMS
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  High toxicity of pure botulinum type D toxin.

Authors:  L M WENTZEL; M STERNE; A POLSON
Journal:  Nature       Date:  1950-10-28       Impact factor: 49.962

6.  Purification and some properties of progenitor toxins of Clostridium botulinum type B.

Authors:  S Kozaki; S Sakaguchi; G Sakaguchi
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

7.  Activation of botulinum toxins in the absence of nicking.

Authors:  I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

8.  Molecular construction of Clostridium botulinum type A toxins.

Authors:  S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

9.  PREPARATION AND ASSAY OF THE INTERNATIONAL STANDARDS FOR CLOSTRIDIUM BOTULINUM TYPES A, B, C, D AND E ANTITOXINS.

Authors:  E J BOWMER
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

10.  Purification of Clostridium botuliunum type F progenitor toxin.

Authors:  I Oishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1974-12
View more
  25 in total

1.  Molecular diversity of neurotoxins from Clostridium botulinum type D strains.

Authors:  K Moriishi; B Syuto; S Kubo; K Oguma
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Clostridium botulinum types A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes?

Authors:  E Somers; B R DasGupta
Journal:  J Protein Chem       Date:  1991-08

Review 3.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

4.  Observations on toxin and hemagglutinin produced by Clostridium botulinum type C.

Authors:  K Oguma; A Nakane; H Iida
Journal:  Appl Environ Microbiol       Date:  1978-02       Impact factor: 4.792

5.  A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D.

Authors:  J Molgó; L S Siegel; N Tabti; S Thesleff
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

6.  Acid precipitation of Clostridium botulinum type C and D toxins from whole culture by addition of ribonucleic acid as a precipitation aid.

Authors:  M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

7.  Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum.

Authors:  E J Rubin; D M Gill; P Boquet; M R Popoff
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

8.  Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F.

Authors:  S Yamasaki; Y Hu; T Binz; A Kalkuhl; H Kurazono; T Tamura; R Jahn; E Kandel; H Niemann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).

Authors:  M Matsuda; K Ozutsumi; P Y Du; N Sugimoto
Journal:  Eur J Epidemiol       Date:  1986-12       Impact factor: 8.082

10.  Oral toxicities of Clostridium botulinum type A and B toxins from different strains.

Authors:  I Ohishi
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.